Showing results (231-240 of 274) with videos related to

Sort By:
Pageof 28
Blood|August 1, 1991
Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for relapsed non-Hodgkin's lymphoma: blood and bone marrow progenitor growth studies. A phase II Eastern Cooperative Oncology Group TrialH M Lazarus, J Andersen, M G Chen, et al.
Cancer|January 1, 1977
Survival of patients with localized histiocytic lymphomaJ D Bitran, J Kinzie, D L Sweet, et al.
Blood|November 15, 1996
Prognostic implications of ploidy and proliferative activity in the diffuse, aggressive non-Hodgkin's lymphomasJ N Winter, J Andersen, D Variakojis, et al.
Atherosclerosis|March 1, 1979
Correlation in the human aorta of APO B fractions with tissue cholesterol and collagen contentH F Hoff, M Karagas, C L Heideman, et al.
Arteriosclerosis (Dallas, Tex.)|May 1, 1984
Cholesterol esterification in macrophages. Stimulation by lipoproteins containing apo B isolated from human aortasB A Clevidence, R E Morton, G West, et al.
The Journal of Investigative Dermatology|December 1, 1990
Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphomaH H Roenigk, T M Kuzel, A P Skoutelis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
Human immunodeficiency virus-related lymphomas: a possible association between tumor proliferation, lack of ploidy anomalies, and immune deficiencyS H McDunn, J N Winter, D Variakojis, et al.
Kidney International|August 5, 1998
Measurement of oxidation in plasma Lp(a) in CAPD patients using a novel ELISAE A Podrez, J O'Neil, R G Salomon, et al.
Gynecologic Oncology|May 1, 1996
Radiation therapy as exclusive treatment for medically inoperable patients with stage I and II endometrioid carcinoma with endometriumD A Fishman, K B Roberts, J T Chambers, et al.
Cancer|March 5, 1998
Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphomaL R Kong, C F Huang, D Hakimian, et al.
Pageof 28